Compound Detail
CHEMBL2070953
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL2070953 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | OXQNLLVUVDAEHC-OAQYLSRUSA-N |
1
Targets
1
Activities
1
Assay Types
4
PK Parameters
20
Publications
0
Known Names
Molecular Properties
471.6
MW (Da)
4.31
ALogP
6
HBA
1
HBD
88.6
PSA (Ų)
0.58
QED
0
Ro5 Violations
6
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
EC50 1 meas. best 6.58
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Potassium voltage-gated channel subfamily KQT member 1 CHEMBL1866 | EC50 | 6.58 | 6.58 | 260.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| CL | 18.0 | mL.min-1.kg-1 | Homo sapiens |
| CL | 64.7 | mL.min-1.kg-1 | Rattus norvegicus |
| Fu | 0.006 | - | Homo sapiens |
| Fu | 0.007 | - | Rattus norvegicus |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Potassium voltage-gated channel subfamily KQT member 1 | EC50 | = | 260.0 | nM | 6.58 | Activation of Kv7.1 channel expressed in CHO cells assessed as depolarization-in... | 22910039 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| - | 10.6019/CHEMBL5303304 | Fibroblast | 18 |
| - | 10.6019/CHEMBL5303304 | HEK-293T | 16 |
| - | 10.6019/CHEMBL5303304 | U2OS | 8 |
| 22910039 | 10.1016/j.bmcl.2012.07.060 | Liver microsomes | 6 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 4 |
| 22910039 | 10.1016/j.bmcl.2012.07.060 | Potassium voltage-gated channel subfamily KQT member 2 | 2 |
| - | 10.6019/CHEMBL4808148 | Histone deacetylase 6 | 2 |
| - | 10.6019/CHEMBL4495564 | Replicase polyprotein 1ab | 2 |
| 22910039 | 10.1016/j.bmcl.2012.07.060 | Plasma | 2 |
| 22910039 | 10.1016/j.bmcl.2012.07.060 | Voltage-gated inwardly rectifying potassium channel KCNH2 | 2 |
| 22910039 | 10.1016/j.bmcl.2012.07.060 | Unchecked | 2 |
| 22910039 | 10.1016/j.bmcl.2012.07.060 | Potassium voltage-gated channel subfamily KQT member 4 | 2 |
| 22910039 | 10.1016/j.bmcl.2012.07.060 | Potassium voltage-gated channel subfamily KQT member 1 | 2 |
| 22910039 | 10.1016/j.bmcl.2012.07.060 | Sodium-dependent dopamine transporter | 1 |
| 22910039 | 10.1016/j.bmcl.2012.07.060 | 5-hydroxytryptamine receptor 2B | 1 |
| 22910039 | 10.1016/j.bmcl.2012.07.060 | Cannabinoid receptor 1 | 1 |
| - | 10.21203/rs.3.rs-23951/v1 | SARS-CoV-2 | 1 |
| 22910039 | 10.1016/j.bmcl.2012.07.060 | Voltage-gated L-type calcium channel | 1 |
| 22910039 | 10.1016/j.bmcl.2012.07.060 | Adenosine receptor A3 | 1 |
| - | 10.6019/CHEMBL5308504 | Casein kinase I isoform delta | 1 |
Data from ChEMBL 36 via Core Engine